Drug name - Halaven

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6214865 EISAI INC Macrocyclic analogs and methods of their use and preparation
Jul, 2023

(9 months from now)

CN1312804A EISAI INC Macrocyclic Analogs And Methods Of Use And Preparation Method
Jun, 2019

(3 years ago)

CN1216051C EISAI INC Macrocyclic Analogs And Methods Of Use And Preparation Method
Jun, 2019

(3 years ago)

EP2277873A1 EISAI INC Intermediate Compound For The Preparation Of Halichondrin Analogs
Jun, 2019

(3 years ago)

EP2272839B1 EISAI INC Intermediate Compounds For The Preparation Of Halichondrin Analogs
Jun, 2019

(3 years ago)

EP2272839A1 EISAI INC Intermediate Compounds For The Preparation Of Halichondrin Analogs
Jun, 2019

(3 years ago)

EP2277873B1 EISAI INC Intermediate Compound For The Preparation Of Halichondrin Analogs
Jun, 2019

(3 years ago)

EP2272840A1 EISAI INC Intermediate Compound For The Preparation Of Halichondrin Analogs
Jun, 2019

(3 years ago)

EP2272840B1 EISAI INC Intermediate Compound For The Preparation Of Halichondrin Analogs
Jun, 2019

(3 years ago)

EP1087960B1 EISAI INC Macrocyclic Analogs And Methods Of Their Use And Preparation
Jun, 2024

(1 year, 8 months from now)

EP1087960A4 EISAI INC Macrocyclic Analogs And Methods Of Their Use And Preparation
Jun, 2024

(1 year, 8 months from now)

EP1087960A1 EISAI INC Macrocyclic Analogs And Methods Of Their Use And Preparation
Jun, 2024

(1 year, 8 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
USRE46965 EISAI INC Intermediates for the preparation of analogs of Halichondrin B Jan, 2027

(4 years from now)

Drugs and Companies using ERIBULIN MESYLATE ingredient

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
1MG/2ML (0.5MG/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.